Correlation Between Oxford Nanopore and ATyr Pharma
Can any of the company-specific risk be diversified away by investing in both Oxford Nanopore and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oxford Nanopore and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oxford Nanopore Technologies and ATyr Pharma, you can compare the effects of market volatilities on Oxford Nanopore and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oxford Nanopore with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oxford Nanopore and ATyr Pharma.
Diversification Opportunities for Oxford Nanopore and ATyr Pharma
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Oxford and ATyr is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Oxford Nanopore Technologies and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Oxford Nanopore is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oxford Nanopore Technologies are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Oxford Nanopore i.e., Oxford Nanopore and ATyr Pharma go up and down completely randomly.
Pair Corralation between Oxford Nanopore and ATyr Pharma
Assuming the 90 days horizon Oxford Nanopore Technologies is expected to generate 0.14 times more return on investment than ATyr Pharma. However, Oxford Nanopore Technologies is 7.38 times less risky than ATyr Pharma. It trades about 0.08 of its potential returns per unit of risk. ATyr Pharma is currently generating about -0.3 per unit of risk. If you would invest 136.00 in Oxford Nanopore Technologies on August 29, 2024 and sell it today you would earn a total of 51.00 from holding Oxford Nanopore Technologies or generate 37.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 6.4% |
| Values | Daily Returns |
Oxford Nanopore Technologies vs. ATyr Pharma
Performance |
| Timeline |
| Oxford Nanopore Tech |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Oxford Nanopore and ATyr Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oxford Nanopore and ATyr Pharma
The main advantage of trading using opposite Oxford Nanopore and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oxford Nanopore position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.The idea behind Oxford Nanopore Technologies and ATyr Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |